Back
ESC2025 Premium Access

Discontinuation of antithrombotic management following left atrial appendage occlusion in high bleeding risk patients

Session: Outcomes and strategies in left atrial appendage closure
Topic: Left Atrial Appendage (LAA) Closure
Speaker: Doctor S. Wong (Brighton, GB)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Siu Fung Wong

Royal Sussex County Hospital, Brighton (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Impact of left atrial appendage closure on events after severe bleeding in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry

Speaker: Doctor M. Ruiz Ortiz (Cordoba, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter case-control study

Speaker: Doctor L. De Luca (Milan, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

An observational analysis of device-related thrombus in patients with atrial fibrillation across different generations of Watchman devices

Speaker: Doctor K. Pant (New York City, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis

Speaker: Doctor A. Samaras (Thessaloniki, GR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Outcomes and strategies in left atrial appendage closure

Speakers: Doctor S. Wong, Doctor M. Ruiz Ortiz, Doctor L. De Luca, Doctor K. Pant, Doctor A. Samaras
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources